410 related articles for article (PubMed ID: 22775390)
1. Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells.
Logadottir Y; Hallsberg L; Fall M; Peeker R; Delbro D
Scand J Urol; 2013 Feb; 47(1):52-6. PubMed ID: 22775390
[TBL] [Abstract][Full Text] [Related]
2. Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis.
Logadottir Y; Delbro D; Lindholm C; Fall M; Peeker R
Int J Urol; 2014 Apr; 21 Suppl 1():75-8. PubMed ID: 24807505
[TBL] [Abstract][Full Text] [Related]
3. Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Logadottir Y; Delbro D; Fall M; Gjertsson I; Jirholt P; Lindholm C; Peeker R
J Urol; 2014 Nov; 192(5):1564-8. PubMed ID: 24813342
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics differ considerably between phenotypes of bladder pain syndrome/interstitial cystitis.
Logadottir Y; Fall M; Kåbjörn-Gustafsson C; Peeker R
Scand J Urol Nephrol; 2012 Oct; 46(5):365-70. PubMed ID: 22607036
[TBL] [Abstract][Full Text] [Related]
5. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
Jhang JF; Hsu YH; Kuo HC
Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
[TBL] [Abstract][Full Text] [Related]
6. Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.
Gamper M; Viereck V; Eberhard J; Binder J; Moll C; Welter J; Moser R
Int Urogynecol J; 2013 Dec; 24(12):2049-57. PubMed ID: 23670165
[TBL] [Abstract][Full Text] [Related]
7. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis.
Koskela LR; Thiel T; Ehrén I; De Verdier PJ; Wiklund NP
J Urol; 2008 Aug; 180(2):737-41. PubMed ID: 18554637
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome/interstitial cystitis type 3C.
Ehrén I; Hallén Grufman K; Vrba M; Sundelin R; Lafolie P
Scand J Urol; 2013 Dec; 47(6):503-8. PubMed ID: 23600529
[TBL] [Abstract][Full Text] [Related]
9. ESSIC criteria for the diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC) and comparison with the NIDDK criteria.
Proaño A; Garde G; Garrido G; Mazza O
Arch Esp Urol; 2013 Mar; 66(2):206-14. PubMed ID: 23589598
[TBL] [Abstract][Full Text] [Related]
10. Clinical Relevance of Bladder Histopathological Findings and Their Impact on Treatment Outcomes among Patients with Interstitial Cystitis/Bladder Pain Syndrome: An Investigation of the European Society for the Study of Interstitial Cystitis Histopathological Classification.
Jhang JF; Hsu YH; Jiang YH; Ho HC; Kuo HC
J Urol; 2021 Jan; 205(1):226-235. PubMed ID: 32856961
[TBL] [Abstract][Full Text] [Related]
11. Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report.
Fall M; Nordling J; Cervigni M; Dinis Oliveira P; Fariello J; Hanno P; Kåbjörn-Gustafsson C; Logadottir Y; Meijlink J; Mishra N; Moldwin R; Nasta L; Quaghebeur J; Ratner V; Sairanen J; Taneja R; Tomoe H; Ueda T; Wennevik G; Whitmore K; Wyndaele JJ; Zaitcev A
Scand J Urol; 2020 Apr; 54(2):91-98. PubMed ID: 32107957
[No Abstract] [Full Text] [Related]
12. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.
Lee CL; Jiang YH; Kuo HC
BJU Int; 2013 Dec; 112(8):1156-62. PubMed ID: 23937072
[TBL] [Abstract][Full Text] [Related]
13. [New insights in the differential diagnosis of bladder pain syndrome].
Schwalenberg T; Neuhaus J; Horn LC; Alexander H; Zimmermann G; Ho Thi P; Mallock T; Stolzenburg JU
Aktuelle Urol; 2010 Mar; 41(2):107-18. PubMed ID: 20309783
[TBL] [Abstract][Full Text] [Related]
14. Effect of amitriptyline in treatment interstitial cystitis or bladder pain syndrome according to two criteria: does ESSIC criteria change the response rate?
Sun Y; Fang Z; Ding Q; Zheng J
Neurourol Urodyn; 2014 Mar; 33(3):341-4. PubMed ID: 23744795
[TBL] [Abstract][Full Text] [Related]
15. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?
Gamper M; Regauer S; Welter J; Eberhard J; Viereck V
J Urol; 2015 Jun; 193(6):1994-2000. PubMed ID: 25596361
[TBL] [Abstract][Full Text] [Related]
16. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.
Kim A; Han JY; Ryu CM; Yu HY; Lee S; Kim Y; Jeong SU; Cho YM; Shin DM; Choo MS
Histopathology; 2017 Sep; 71(3):415-424. PubMed ID: 28394416
[TBL] [Abstract][Full Text] [Related]
17. Enhanced urothelial expression of human chorionic gonadotropin beta (hCGβ) in bladder pain syndrome/interstitial cystitis (BPS/IC).
Schwalenberg T; Stolzenburg JU; Ho TP; Mallock T; Hartenstein S; Alexander H; Zimmermann G; Hohenfellner R; Denzinger S; Burger M; Horn LC; Neuhaus J
World J Urol; 2012 Jun; 30(3):411-7. PubMed ID: 21877171
[TBL] [Abstract][Full Text] [Related]
18. Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study.
Charrua A; Pinto R; Taylor A; Canelas A; Ribeiro-da-Silva A; Cruz CD; Birder LA; Cruz F
Neurourol Urodyn; 2015 Jun; 34(5):489-96. PubMed ID: 24375689
[TBL] [Abstract][Full Text] [Related]
19. Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome.
Whitmore KE; Fall M; Sengiku A; Tomoe H; Logadottir Y; Kim YH
Int J Urol; 2019 Jun; 26 Suppl 1():26-34. PubMed ID: 31144757
[TBL] [Abstract][Full Text] [Related]
20. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
